Bendanit^®

Bendamustine

Keep the game balanced

Product Information

Proprietary Name: Bendanit®
Generic Name: Bendamustine
Dosage Form: Vial
Strengths: 25 mg, 100 mg
Indications: Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma

Download Leaflet

Oncology

Bendanit®

Bendamustine is indicated for the treatment of chronic lymphocytic leukemia (CLL), and non-hodgkin lymphoma.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.